FDA Drug · D-1330-2022

Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd., Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-785-06.

Class II · Terminated

Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets

Affected lots / codes — check yours against thisLot #: 7248988B, Exp 9/2023

Recalling firm: Strides Pharma Inc., East Brunswick, NJ
Classification: Class II (temporary or reversible harm possible)
Status: Terminated
Quantity: 1032 bottles
Distribution: US Nationwide
Recall initiated: July 19, 2022
Classified: August 9, 2022
Terminated: June 21, 2023
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1330-2022%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →